Geron Enhances Oncology Expertise to Advance Corporate Objectives

    NEXT STORY
    Genmab Announces Submission of Extension of Marketing Authorization to European Medicines Agency for Subcutaneous Formulation of Daratumumab
    PREV STORY
    Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for Initiation of a Global Phase 2 Trial for TransCon™ CNP in Children with Achondroplasia
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Myriad Presents Two New Studies at the Western Section of the American Urological Association

    New Data Demonstrate the Clinical Performance of the Prolaris® and myRisk® Hereditary Cancer Genetic ...

    author_avatar
    NASDAQ Market News

    Zai Lab Limited Announces Dosing of First Patient in Phase 3 Registration Trial of ZL-2306 (niraparib) for Treatment of Ovarian Cancer

    SHANGHAI, China, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based ...

    author_avatar
    NASDAQ Market News

    Global Antifungal Drugs Market Analysis, Forecast & Opportunities, 2013-2018 & 2023 – Azoles Class Antifungals are Predicted to Hold their Dominant Position in the Market

    author_avatar
    NASDAQ Market News